NDC 67184-0540 – Fosaprepitant Dimeglumine
Fosaprepitant Dimeglumine 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC67184-0540
Product details
- Brand name
- Fosaprepitant Dimeglumine
- Generic name
- Fosaprepitant Dimeglumine
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- ANDA · ANDA213106
- Marketed since
- September 8, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
Active ingredients
- Fosaprepitant Dimeglumine 150 mg/5mL
Uses, dosage, side effects and warnings for Fosaprepitant Dimeglumine →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 67184-0540-1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (67184-0540-1) / 5 mL in 1 VIAL, SINGLE-DOSE | Sep 8, 2020 |
Other Fosaprepitant Dimeglumine products
- 55150-299 Fosaprepitant Dimeglumine 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · Eugia US LLC
- 0143-9384 Fosaprepitant Dimeglumine 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · Hikma Pharmaceuticals USA Inc.
- 0143-9428 Fosaprepitant Dimeglumine 150 mg/5mL · Injection, Powder, Lyophilized, For Solution · Hikma Pharmaceuticals USA Inc.